Cervical cancer: EGFR overexpression linked to decreased survival
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- EGFR overexpression might be a predictive biomarker of reduced survival in patients with cervical cancer; these findings could help facilitate treatment decisions.
- Meta-analysis that included 22 studies with 2505 patients that investigated the association between EGFR expression and survival in cervical cancer.
- Funded by the Guangdong Province Medical Science Technology and the Guangdong Pharmaceutical Association Fund.
- High EGFR levels predicted poor OS (HR, 1.40; 95% CI, 1.10-1.78), as well as DFS (HR, 1.84; 95% CI, 1.51-2.24).
- EGFR overexpression was significantly related to poor DFS among patients who received chemoradiation or surgery.
- Pooled ORs showed associations between EGFR expression and several clinicopathologica...